Algorithm to Stratify Clinical Decompensation Risk in Patients With Compensated Advanced Chronic Liver Disease (CHESS2108)
A Novel Algorithm to Stratify Clinical Decompensation Risk in Patients With Compensated Advanced Chronic Liver Disease (CHESS2108)
Sponsor: Changi General Hospital
Listed as NCT05100485, this observational or N/A phase trial focuses on Compensated Advanced Chronic Liver Disease and remains completed. Sponsored by Changi General Hospital, it has been updated 5 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
May 2023 — Jul 2024 [monthly]
Completed
Status: Not Yet Recruiting → Completed
-
Feb 2023 — May 2023 [monthly]
Not Yet Recruiting
-
Nov 2021 — Feb 2023 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Changi General Hospital
- Ehime University Graduate School of Medicine
- Hepatopancreatobiliary Surgery Institute of Gansu Province
- Hyogo Medical University
- Institute of Liver and Biliary Sciences (ILBS)
- Korea University Ansan Hospital
- Ruijin Hospital
- The Third People's Hospital of Taiyuan
- Tianjin Second People's Hospital
- Zagazing University Faculty of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .